Assembly Biosciences, Inc. ( ASMB) - Key Metrics
ASMB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.20 | -$0.82 | -$0.82 |
| 2026Q1 | $0.49 | -$0.54 | -$1.31 | -$1.31 |
| 2025Q4 | $3.79 | $1.97 | $1.27 | $1.27 |
| 2025Q3 | $1.41 | -$1.20 | -$1.98 | -$1.98 |
| 2025Q2 | $1.26 | -$1.33 | -$2.19 | -$2.19 |
ASMB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -34.35 |
| 2026Q1 | 0% | -12.85 |
| 2025Q4 | 0% | 3.41 |
| 2025Q3 | 0% | -5.33 |
| 2025Q2 | 0% | -3.41 |
ASMB
Price: $32.95
52 week price:
Earnings Per Share: 0.09 USD
P/E Ratio: 332.78
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 311844
Ebitda: -12.4 millionMarket Capitalization: 593.5 million